|
1
|
Horton R: Offline: 2019-nCoV
outbreak-early lessons. Lancet. 395:3222020. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
World Health Organization (WHO):
Coronavirus disease (COVID-2019) situation report. WHO; Geneva:
2021, https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports
Accessed July 19, 2021.
|
|
3
|
Wan MY, Zhao R, Gao LJ, Gao XF, Wang DP
and Cao JM: SARS-CoV-2: Structure, biology, and structure-based
therapeutics development. Front Cell Infect Microbiol.
10:5872692020. View Article : Google Scholar
|
|
4
|
Hoffmann M, Kleine-Weber H, Schroeder S,
Krüger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH,
Nitsche A, et al: SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2
and is blocked by a clinically proven protease inhibitor. Cell.
181:271–280.e8. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Xiao L, Sakagami H and Miwa N: ACE2: The
key molecule for understanding the pathophysiology of severe and
critical conditions of COVID-19: Demon or angel? Viruses.
12:4912020. View Article : Google Scholar
|
|
6
|
Kuba K, Imai Y and Penninger JM: Multiple
functions of angiotensin-converting enzyme 2 and its relevance in
cardiovascular diseases. Circ J. 77:301–308. 2013. View Article : Google Scholar
|
|
7
|
Patel VB, Zhong JC, Grant MB and Oudit GY:
Role of the ACE2/angiotensin 1-7 axis of the renin-angiotensin
system in heart failure. Circ Res. 118:1313–1326. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Turner AJ, Hiscox JA and Hooper NM: ACE2:
From vasopeptidase to SARS virus receptor. Trends Pharmacol Sci.
25:291–294. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gheblawi M, Wang K, Viveiros A, Nguyen Q,
Zhong JC, Turner AJ, Raizada MK, Grant MB and Oudit GY:
Angiotensin-converting enzyme 2: SARS-CoV-2 receptor and regulator
of the renin-angiotensin system: Celebrating the 20th anniversary
of the discovery of ACE2. Circ Res. 126:1456–1474. 2020. View Article : Google Scholar
|
|
10
|
Danilczyk U and Penninger JM:
Angiotensin-converting enzyme II in the heart and the kidney. Circ
Res. 98:463–471. 2006. View Article : Google Scholar
|
|
11
|
Su H, Yang M, Wan C, Yi LX, Tang F, Zhu
HY, Yi F, Yang HC, Fogo AB, Nie X and Zhang C: Renal
histopathological analysis of 26 postmortem findings of patients
with COVID-19 in China. Kidney Int. 98:219–227. 2020. View Article : Google Scholar
|
|
12
|
Zipeto D, Palmeira JDF, Argañaraz GA and
Argañaraz ER: ACE2/ADAM17/TMPRSS2 interplay may be the main risk
factor for COVID-19. Front Immunol. 11:5767452020. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lambert DW, Yarski M, Warner FJ, hornhill
P, Parkin ET, Smith AI, Hooper NM and Turner AJ: Tumor necrosis
factor-alpha convertase (ADAM17) mediates regulated ectodomain
shedding of the severe-acute respiratory syndrome-coronavirus
(SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2). J Biol
Chem. 280:30113–30119. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kuba K, Imai Y, Rao S, Gao H, Guo F, Guan
B, Huan Y, Yang P, Zhang Y, Deng W, et al: A crucial role of
angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced
lung injury. Nat Med. 11:875–879. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang S, Guo F, Liu K, Wang H, Rao S, Yang
P and Jiang C: Endocytosis of the receptor-binding domain of
SARS-CoV spike protein together with virus receptor ACE2. Virus
Res. 136:8–15. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Patel VB, Clarke N, Wang Z, Fan D,
Parajuli N, Basu R, Putko B, Kassiri Z, Turner AJ and Oudit GY:
Angiotensin ii induced proteolytic cleavage of myocardial ACE2 is
mediated by TACE/ADAM-17: A positive feedback mechanism in the RAS.
J Mol Cell Cardiol. 66:167–176. 2014. View Article : Google Scholar
|
|
17
|
Palau V, Riera M and Soler MJ: ADAM17
inhibition may exert a protective effect on COVID-19. Nephrol Dial
Transplant. 35:1071–1072. 2020. View Article : Google Scholar
|
|
18
|
Saliminejad K, Khorram Khorshid HR,
Soleymani Fard S and Ghaffari SH: An overview of microRNAs:
Biology, functions, therapeutics, and analysis methods. J Cell
Physiol. 234:5451–5465. 2019. View Article : Google Scholar
|
|
19
|
Biswas S, Haleyurgirisetty M, Lee S,
Hewlett I and Devadas K: Development and validation of plasma miRNA
biomarker signature panel for the detection of early HIV-1
infection. EBioMedicine. 43:307–316. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Park S, Eom K, Kim J, Bang H, Wang HY, Ahn
S, Kim G, Jang H, Kim S, Lee D, et al: MiR-9, miR-21, and miR-155
as potential biomarkers for HPV positive and negative cervical
cancer. BMC cancer. 17:6582017. View Article : Google Scholar :
|
|
21
|
Khan MA, Sany MRU, Islam MS and Islam
ABMMK: Epigenetic regulator mirna pattern differences among
SARS-CoV, SARS-CoV-2, and SARS-CoV-2 World-Wide isolates delineated
the mystery behind the epic pathogenicity and distinct clinical
characteristics of pandemic COVID-19. Front Genet. 11:7652020.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang G, Dong F, Xu Z, Sharma S, Hu X, Chen
D, Zhang L, Zhang J and Dong Q: MicroRNA profile in HBV-induced
infection and hepatocellular carcinoma. BMC cancer. 17:8052017.
View Article : Google Scholar :
|
|
23
|
Bai XT and Nicot C: miR-28-3p is a
cellular restriction factor that inhibits human T cell leukemia
virus, type 1 (HTLV-1) replication and virus infection. J Biol
Chem. 290:5381–5390. 2015. View Article : Google Scholar
|
|
24
|
Ma L, Zhang YF and Hu F: miR-28-5p
inhibits the migration of breast cancer by regulating WSB2. Int J
Mol Med. 46:1562–1570. 2020.PubMed/NCBI
|
|
25
|
Zhu G, Wang Z, Mijiti M, Du G, Li Y and
Dangmurenjiafu G: MiR-28-5p promotes human glioblastoma cell growth
through inactivation of FOXO1. Int J Clin Exp Pathol. 12:2972–2980.
2019.
|
|
26
|
Fan HN, Liao XH, Zhang J and Zheng HM:
Macrophages promote cell proliferation in colorectal cancer via
IL-1β-mediated downregulation of miR-28-3p. J Biol Regul Homeost
Agents. 34:1657–1668. 2020.PubMed/NCBI
|
|
27
|
Zhou X, Wen W, Shan X, Qian J, Li H, Jiang
T, Wang W, Cheng W, Wang F, Qi L, et al: MiR-28-3p as a potential
plasma marker in diagnosis of pulmonary embolism. Thromb Res.
138:91–95. 2016. View Article : Google Scholar
|
|
28
|
Tiwari A, Mukherjee B and Dixit M:
MicroRNA key to angiogenesis regulation: MiRNA biology and therapy.
Curr Cancer Drug Targets. 18:266–277. 2018. View Article : Google Scholar
|
|
29
|
Purohit V, Rapaka RS, Rutter J and
Shurtleff D: Do opioids activate latent HIV-1 by down-regulating
anti-HIV microRNAs? J Neuroimmune Pharmacol. 7:519–523. 2012.
View Article : Google Scholar
|
|
30
|
Tandon R, Sharp JS, Zhang F, Pomin VH,
Ashpole NM, Mitra D, Jin W, Liu H, Sharma P and Linhardt RJ:
Effective inhibition of SARS-CoV-2 entry by heparin and enoxaparin
derivatives. J Virol. 95:e019872021. View Article : Google Scholar
|
|
31
|
Zhang Y, Hu S, Wang J, Xue Z, Wang C and
Wang N: Dexamethasone inhibits SARS-CoV-2 spike pseudotyped virus
viropexis by binding to ACE2. Virology. 554:83–88. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hu S, Wang J, Zhang Y, Bai H, Wang C, Wang
N and He L: Three salvianolic acids inhibit 2019-nCoV spike
pseudovirus viropexis by binding to both its RBD and receptor ACE2.
J Med Virol. 93:3143–3151. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Gao J, Ding Y, Wang Y, Liang P, Zhang L
and Liu R: Oroxylin A is a severe acute respiratory syndrome
coronavirus 2-spiked pseudotyped virus blocker obtained from Radix
Scutellariae using angiotensin-converting enzyme II/cell membrane
chromatography. Phytother Res. 35:3194–3204. 2021. View Article : Google Scholar
|
|
34
|
Haga S, Yamamoto N, Nakai-Murakami C,
Osawa Y, Tokunaga K, Sata T, Yamamoto N, Sasazuki T and Ishizaka Y:
Modulation of TNF-alpha-converting enzyme by the spike protein of
SARS-CoV and ACE2 induces TNF-alpha production and facilitates
viral entry. Proc Natl Acad Sci USA. 105:7809–7814. 2008.
View Article : Google Scholar
|
|
35
|
Yang ZY, Huang Y, Ganesh L, Leung K, Kong
WP, Schwartz O, Subbarao K and Nabel GJ: pH-dependent entry of
severe acute respiratory syndrome coronavirus is mediated by the
spike glycoprotein and enhanced by dendritic cell transfer through
DC-SIGN. J Virol. 78:5642–5650. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
37
|
Wu Y: Compensation of ACE2 function for
possible clinical management of 2019-nCoV-induced acute lung
injury. Virol Sin. 35:256–258. 2020. View Article : Google Scholar :
|
|
38
|
Moore MJ, Dorfman T, Li W, Wong SK, Li Y,
Kuhn JH, Coderre J, Vasilieva N, Han Z, Greenough TC, et al:
Retroviruses pseudotyped with the severe acute respiratory syndrome
coronavirus spike protein efficiently infect cells expressing
angiotensin-converting enzyme 2. J Virol. 78:10628–10635. 2004.
View Article : Google Scholar
|
|
39
|
Wrapp D, Wang N, Corbett KS, Goldsmith JA,
Hsieh CL, Abiona O, Graham BS and McLellan JS: Cryo-EM structure of
the 2019-nCoV spike in the prefusion conformation. Science.
367:1260–1263. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wang Q, Zhang Y, Wu L, Niu S, Song C,
Zhang Z, Lu G, Qiao C, Hu Y, Yuen KY, et al: Structural and
functional basis of SARS-CoV-2 entry by using Human ACE2. Cell.
181:894–904.e9. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Taneera J, El-Huneidi W, Hamad M, Mohammed
AK, Elaraby E and Hachim MY: Expression profile of SARS-CoV-2 host
receptors in human pancreatic islets revealed upregulation of ACE2
in diabetic donors. Biology (Basel). 9:2152020.
|
|
42
|
de Loyola MB, Dos Reis TTA, de Oliveira
GXLM, da Fonseca Palmeira J, Argañaraz GA and Argañaraz ER:
Alpha-1-antitrypsin: A possible host protective factor against
Covid-19. Rev Med Virol. 31:e21572021. View Article : Google Scholar
|
|
43
|
Heurich A, Hofmann-Winkler H, Gierer S,
Liepold T, Jahn O and Pöhlmann S: TMPRSS2 and ADAM17 cleave ACE2
differentially and only proteolysis by TMPRSS2 augments entry
driven by the severe acute respiratory syndrome coronavirus spike
protein. J Virol. 88:1293–1307. 2014. View Article : Google Scholar :
|
|
44
|
Zunke F and Rose-John S: The shedding
protease ADAM17: Physiology and pathophysiology. Biochim Biophys
Acta Mol Cell Res. 1864:2059–2070. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Das G, Mukherjee N and Ghosh S:
Neurological insights of COVID-19 pandemic. ACS Chem Neurosci.
11:1206–1209. 2020. View Article : Google Scholar
|
|
46
|
Trobaugh DW and Klimstra WB: MicroRNA
regulation of RNA virus replication and pathogenesis. Trends Mol
Med. 23:80–93. 2017. View Article : Google Scholar
|
|
47
|
Zhang H, Rostami MR, Leopold PL, Mezey JG,
O'Beirne SL, Strulovici-Barel Y and Crystal RG: Expression of the
SARS-CoV-2 ACE2 receptor in the human airway epithelium. Am J
Respir Crit Care Med. 202:219–229. 2020. View Article : Google Scholar : PubMed/NCBI
|
